Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMOTE-PEDS: PI vs NNRTI for Malaria Prevention in HIV Children
NCT00978068Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lopinavir + ritonavir in malaria, sponsored by University of California, San Francisco. Started Sep 2009; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00978068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00978068.